In this study, we revealed a protective role of GPNMB in obesity-related metabolic disorders largely through reducing macrophage inflammability, and thus GPNMB activation may provide a therapeutic strategy in obesity and diabetes. Here, GPNMB is linked to obesity due to melanocortin 4 receptor deficiency.